Skip to content

Evaluation of clinical effect of Wei's manipulation combined with transcutaneous electrical nerve stimulation (TENS) in the treatment of lumbar intervertebral disc hernia

Evaluation of clinical effect of Wei's manipulation combined with transcutaneous electrical nerve stimulation (TENS) in the treatment of lumbar intervertebral disc hernia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000381
Enrollment
Unknown
Registered
2024-09-05
Start date
2024-09-30
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar disc herniation

Interventions

Treatment group
:wei's manipulation and Transcutaneous electrical nerve stimulation therapy
control group:wei's manipulation treatment

Sponsors

The Ruijin Hospital Afiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1) To meet the diagnostic criteria for lumbar disc herniation refer to the relevant contents of the "Consensus of Chinese Pain Experts on the Diagnosis and Treatment of Lumbar disc herniation". 2) Sign a dated informed consent commit to abide by the research procedures and cooperate with the implementation of the whole process of the study. 3) Aged 18-50. 4) Patients with unilateral lumbago or numbness of lumbago and leg pain.

Exclusion criteria

Exclusion criteria: 1)noncooperate with the completion of data collection or incomplete data 2) Patients with lumbar spine fracture or local bone diseases such as tuberculosis and tumor 3) Patients with serious primary diseases such as cardiovascular liver kidney or hematopoietic system. Other autoimmune diseases allergic diseases acute and chronic infections 4) Mental patients or female patients with severe menopausal symptoms 5) Pregnant or lactating women 6) Experimental studies of other treatments for this disease are being conducted within 2 weeks

Design outcomes

Primary

MeasureTime frame
Effectiveness evaluation;

Secondary

MeasureTime frame
Tender point assessment;ODI;Japanese Orthopaedic Association ScoresJOA;Visual analog rating scale;Assessment of muscle tissue status;

Countries

china

Contacts

Public Contactxuebin

The Ruijin Hospital Afiliated to Shanghai Jiao Tong University School of Medicine

skxuebin@163.com18817821387

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026